2011Unpublished venueRequires access

C-myc and PCNA expression in lung cancer and its significance

YI Huancong

Open publisher page 0 citations

Abstract

Objective:To investigate the expression of C-myc and PCNA(proliferating cell nuclear antigen) in lung cancer and normal lung tissue or lung tissue of bullae and the relationship to the development of lung cancer.Methods: Immunohistochemical staining was used to measure expression of C-myc and PCNA in 50 patients with primary lung cancer(squamous cell carcinoma in 24 cases,19 cases of adenocarcinoma,adenosquamous carcinoma in 4 cases,3 cases of small cell lung cancer) and 16 normal lung tissues or lung bullae tissue.Results: The expression of C-myc,PCNA positive rates were 66%(33/50),74%(37/50) in total of 50 cases of primary lung cancer,no expression of two antibodies observed in normal tissue.The expression of C-myc and PCNA positive rate was significantly higher in lung cancer than lung tissue,and there was no expression of C-myc in 3 cases of small cell lung cancer.Conclusion: C-myc expression in lung cancer was no correlation to PCNA;increased expression of C-myc and PCNA which was developed in the early stage in lung cancer had no association with the staging of lung cancer;they may be related to the development of lung cancer and are helpful to the early diagnosis and molecular targeting therapy.

About this research paper

What this paper is about

Objective:To investigate the expression of C-myc and PCNA(proliferating cell nuclear antigen) in lung cancer and normal lung tissue or lung tissue of bullae and the relationship to the development of lung cancer.Methods: Immunohistochemical staining was used to measure expression of C-myc and PCNA in 50 patients with primary lung cancer(squamous cell carcinoma in 24 cases,19 cases of adenocarcinoma,adenosquamous carcinoma in 4 cases,3 cases of small cell lung cancer) and 16 normal lung tissues or lung bullae tissue.Results: The expression of C-myc,PCNA positive rates were 66%(33/50),74%(37/50) in total of 50 cases of primary lung cancer,no expression of two antibodies observed in normal tissue.The expression of C-myc and PCNA positive rate was significantly higher in lung cancer than lung tissue,and there was no expression of C-myc in 3 cases of small cell lung cancer.Conclusion: C-myc expression in lung cancer was no correlation to PCNA;increased expression of C-myc and PCNA which was developed in the early stage in lung cancer had no association with the staging of lung cancer;they may be related to the development of lung cancer and are helpful to the early diagnosis and molecular targeting therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the expression of C-myc and PCNA(proliferating cell nuclear antigen) in lung cancer and normal lung tissue or lung tissue of bullae and the relationship to the development of lung cancer.Methods: Immunohistochemical staining was used to measure expression of C-myc and PCNA in 50 patients with primary lung cancer(squamous cell carcinoma in 24 cases,19 cases of adenocarcinoma,adenosquamous carcinoma in 4 cases,3 cases of small cell lung cancer) and 16 normal lung tissues or lung bullae tissue.Results: The expression of C-myc,PCNA positive rates were 66%(33/50),74%(37/50) in total of 50 cases of primary lung cancer,no expression of two antibodies observed in normal tissue.The expression of C-myc and PCNA positive rate was significantly higher in lung cancer than lung tissue,and there was no expression of C-myc in 3 cases of small cell lung cancer.Conclusion: C-myc expression in lung cancer was no correlation to PCNA;increased expression of C-myc and PCNA which was developed in the early stage in lung cancer had no association with the staging of lung cancer;they may be related to the development of lung cancer and are helpful to the early diagnosis and molecular targeting therapy.

Key concepts: Proliferating cell nuclear antigen, Lung cancer, Immunohistochemistry, Adenosquamous carcinoma, Adenocarcinoma, Lung, Pathology, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
C-myc and PCNA expression in lung cancer and its significance — Research Paper | ScholarLens